| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/15/2008 | WO2008057930A2 Methods of treating neuropathic pain with retinoic acid receptor agonists |
| 05/15/2008 | WO2008057246A2 Method for treating inflammatory disorders |
| 05/15/2008 | WO2008057136A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056433A1 Dendritic polyamidoamine phthalocyanine derivative |
| 05/15/2008 | US20080114281 Transdermal Delivery System for Polynucleotides |
| 05/15/2008 | US20080114070 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/15/2008 | US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114024 such as 5-(3-Aminopropylamino)-2-benzyloxy-7-(4-methoxyphenyl)-[1,6]naphthyridine; spleen tyrosine kinase inhibitor; controlling activation of mast cells; antiallergens, antiinflamamtory agents; asthma, chronic obstructive pulmonary disease (COPD), Crohn's disease, bronchitis, conjunctivitis, psoriasis |
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080114014 Treating urinary and fecal incontinence in a patient being treated for a cognitive disorder consisting of one of a group of acute dementia and cognitive impairment by administration of a therapeutic amount of a quaternary ammonium anti-cholinergic muscarinic receptor antagonist |
| 05/15/2008 | US20080114000 Suppressor of excess accumulation of intracellular sodium ions |
| 05/15/2008 | US20080113993 Barbituric acid analogs as therapeutic agents |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113973 Pharmaceutical composition in unit dose form which contains a COX-2 inhibitor and a thromboxane A2 receptor antagonist; for treatment of pain or inflammation; less risk of inducing adverse cardiovascular effects than when COX-2 inhibitors are administered alone |
| 05/15/2008 | US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 05/15/2008 | US20080113965 Skeletal muscle protecting agent |
| 05/15/2008 | US20080113960 Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113955 Treatment of various patient populations at lower doses of stannsoporfin (tin (IV) mesoporphyrin IX dichloride) than previously believed effective, providing advantages in therapeutic administration; liver disorders |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113931 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, substantially complementary to at least part of an mRNA transcript of an Aha gene; cancer or cystic fibrosis |
| 05/15/2008 | US20080113928 Modified Cea/B7 Vector |
| 05/15/2008 | US20080113918 Oral, intravenous, skin or nasal dosage form of agonist polypeptide containing amino acid sequence FCIGRL with less than 100 amino acid residues in length; antiinflmmatory agents |
| 05/15/2008 | US20080113914 Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid |
| 05/15/2008 | US20080113910 Polypeptides or peptides with no risk for viral infection, pathogens, prions; not evoke immune response; gelatine consists of native human collagen sequences; coating on scaffolds for tissue engineering, implant, transplant materials; component of drug delivery systems for inhibition of cancer metastasis |
| 05/15/2008 | US20080113908 Use of CRF receptor agonists for the treatment or Prophylaxis of diseases, for example Neurodegenerative diseases |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113015 drug delivery devices comprising capsules containing drugs distributed within an aqueous phase in the interior of the capsule |
| 05/15/2008 | US20080112998 Innovative bottom-up cell assembly approach to three-dimensional tissue formation using nano-or micro-fibers |
| 05/15/2008 | US20080112995 Implantable Bioreactors and Uses Thereof |
| 05/15/2008 | US20080112973 Chimeric papillomavirus-like particles |
| 05/15/2008 | US20080112965 Chlamydia OMP antigen |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112949 Optimized dosing with anti-CD4 antibodies for tolerance induction in primates |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | US20080112936 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 05/15/2008 | US20080112935 Using fibroblast culture to treat spincter structure malfunction; tissue engineering; regenerative medicine |
| 05/15/2008 | US20080112926 Preparing chimeric polypeptide comprising glycosaminoglycan-binding proteins (GAG) for use in prevention and treatment of skin, nervous system and inflammatory disorders |
| 05/15/2008 | US20080112917 Sphingolipids' Polyalkylamines Conjugates |
| 05/15/2008 | US20080112888 Igfbp2 biomarker |
| 05/15/2008 | CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | CA2668162A1 Use of organic compounds |
| 05/14/2008 | EP1921143A2 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 05/14/2008 | EP1921136A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1921074A1 Thiazole derivative |
| 05/14/2008 | EP1921066A1 Pyridylphenol compound and use thereof |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920770A1 Therapeutic agent for inflammatory bowel disease and tnf- alpha production inhibitor |
| 05/14/2008 | EP1919495A2 Methods and compositions for treating gastrointestinal radiosensitivity in a subject |
| 05/14/2008 | EP1919477A1 Method of improving wakefulness |
| 05/14/2008 | EP1919473A1 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same |
| 05/14/2008 | EP1919458A2 Enterically coated cysteamine, cystamine and derivatives thereof |
| 05/14/2008 | EP1506009B1 Beta-glucan-based anti-fungal vaccines |
| 05/14/2008 | EP1496875B1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1453531B1 Use of hmgb proteins and nucleic acids that code therefor |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1383890B1 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1274429B1 Topical formulations for the transdermal delivery of niacin prodrugs and methods of treating hyperlipidemia |
| 05/14/2008 | EP1248600B1 Improved hiv protease inhibitors pharmaceutical formulations |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1087997B1 Monoclonal antibodies directed against the g3bp protein, and uses |
| 05/14/2008 | EP0840749B1 The h-y antigen |
| 05/14/2008 | CN101177438A N-acetylglucosamine derivatives and use thereof |
| 05/14/2008 | CN101177427A Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same |
| 05/14/2008 | CN101176787A Method for chemoprevention of prostate cancer |
| 05/14/2008 | CN101176768A Epityphlon health |
| 05/14/2008 | CN101176705A Bubble bath preparations for preventing and relieving human body microcirculation disorder |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387576C Substituted phenylalkanoic acid derivatives and use thereof |
| 05/14/2008 | CN100387226C Cepharanthine oral disintegration tablet and its preparing method |
| 05/14/2008 | CN100387144C Method for preparing digestion-promoting spleen-invigorating soybean milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
| 05/14/2008 | CN100387143C Method for preparing yang-invigorating, fatigue-alleviating soybean milk powder with micron pine pollen, antler powder, deer bone powder, deer sinew powder, bull penis powder and donkey penis powder |
| 05/14/2008 | CN100387142C Method for preparing yin-nourishing health-preserving soybean milk powder with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
| 05/14/2008 | CN100387141C Method for preparing yin-nourishing health-preserving soybean milk powder with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
| 05/14/2008 | CN100387136C Method for preparing milk liquor contg. micron additives for tonifying-Yin and eliminating fatigue |
| 05/14/2008 | CN100387126C Method of increasing content of flavonoids and phenolic substances in plants |
| 05/13/2008 | US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371865 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371779 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones |
| 05/13/2008 | US7371773 2-(3,4-dimethoxy-phenyl)-3-(4-hydroxy-phenyl)-acrylonitrile; drug transporter, which actively transports an anticancer drug out of cancer cells, antagonist; improve drug resistance; anticarcinogenic agent; enhance bioavailability of anticancer drug |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |